BREAKTHROUGHS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, offering promising progress across various clinical and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA gives a safer, additional responsible choice for therapeutic use, significantly